Bush Family Dog Succumbs to Lymphoma
The Scottish terrier George W. Bush gave to then First Lade Laura Bush in 2005 has died, according to a statement by the former president.
Miss Beazley was often seen with the then-president and his family during their years in the White House, but she has been "put to rest after a battle with lymphoma," in the words of Mr. Bush.
"She was a source of joy during our time in Washington and in Dallas," his statement read, issued from the Dallas home he shares with Laura. "She was a close companion to her blood relative, Barney. And even though he received all the attention, Beazley never held a grudge against him. She was a guardian to our cats, Bob and Bernadette, who - like Laura and I -- will miss her,"
Both Barney and Miss Beazley were featured in a White House Christmas video in 2005 called "A Very Beazley Christmas."
Feature photo credit: Reuters/Yuri Gripas
Source: Reuters
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
